2023
DOI: 10.1016/j.pathol.2022.12.145
|View full text |Cite
|
Sign up to set email alerts
|

Panfungal PCR on formalin fixed paraffin embedded tissue – to proceed or not proceed?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…In view of this, in the absence of routine fungal culture, proceeding with further molecular investigations on tissue blocks in which histopathology analysis demonstrated the presence of fungal elements will go a long way to influence drug options while providing data on emerging or rare species causing human infections. 19 , 20 This is extremely important in the Ghanaian clinical setting particularly considering the critical role of histopathology in aiding diagnosis and in most instances the commonly available means of diagnosis. 4 Despite the common use of molecular methods on formalin-fixed-paraffin-embedded to aid species-level identification in many clinical mycology laboratories, the methodology or procedures of available assays are not extensively standardized and not available in many African settings.…”
Section: Discussionmentioning
confidence: 99%
“…In view of this, in the absence of routine fungal culture, proceeding with further molecular investigations on tissue blocks in which histopathology analysis demonstrated the presence of fungal elements will go a long way to influence drug options while providing data on emerging or rare species causing human infections. 19 , 20 This is extremely important in the Ghanaian clinical setting particularly considering the critical role of histopathology in aiding diagnosis and in most instances the commonly available means of diagnosis. 4 Despite the common use of molecular methods on formalin-fixed-paraffin-embedded to aid species-level identification in many clinical mycology laboratories, the methodology or procedures of available assays are not extensively standardized and not available in many African settings.…”
Section: Discussionmentioning
confidence: 99%
“…Other techniques such as culture may be limited by their slow growth time that takes up to 4 or more weeks, and the histopathological yield may be lower (79%), probably due to their wide interobserver variability and difficult distinction of conidia 10 . Molecular assays such as amplification and sequencing of ITS2 and D2 region of 28S ribosomal RNA from clinical specimens are now available with sensitivity and specificity of 97% and 98%, respectively, and in cases where fresh tissue is not available, and histopathology demonstrates non‐specific structures with preliminarily negative cultures, paraffin‐embedded Panfungal PCR can be useful and quickly tool to guide early diagnosis and therapy 11 …”
Section: Discussionmentioning
confidence: 99%
“…Polymerase chain reaction and next-generation sequencing (NGS) techniques can be leveraged to identify emerging fungal pathogens from lung tissue, bronchial lavage samples, and blood. PCR offers excellent specificity, but the sensitivity in tissue samples varies widely (64–97%), largely depending on the specimen type (body fluid, fresh tissue, or formalin-fixed paraffin-embedded tissue) and site of sampling (sterile or nonsterile) [56,59 ▪▪ ]. A panfungal PCR that detects fungi through the amplification of the internal transcriber region (ITS) or 18s ribosomal RNA gene, followed by DNA sequencing, is commercially available for the molecular diagnosis of the organisms included in this review.…”
Section: Diagnosismentioning
confidence: 99%
“…A panfungal PCR that detects fungi through the amplification of the internal transcriber region (ITS) or 18s ribosomal RNA gene, followed by DNA sequencing, is commercially available for the molecular diagnosis of the organisms included in this review. Its sensitivity is highest with fresh tissue and when a large sample is available [59 ▪▪ ]. Its use is cost-effective when fungal structures are seen on histopathology but cultures are negative; accordingly, the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC-MSGERC) do not support its use when histopathology does not show yeasts or hyphae [60].…”
Section: Diagnosismentioning
confidence: 99%